-
1
-
-
16244415869
-
Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain
-
Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J; Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis. 2005;11:546-53.
-
(2005)
Emerg Infect Dis
, vol.11
, pp. 546-553
-
-
Oteo, J.1
Lázaro, E.2
de Abajo, F.J.3
Baquero, F.4
Campos, J.5
-
2
-
-
0034075360
-
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997-1998
-
DOI: 10.1086/313710
-
Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997-1998. Clin Infect Dis. 2000;30:454-60. DOI: 10.1086/313710
-
(2000)
Clin Infect Dis
, vol.30
, pp. 454-460
-
-
Fluit, A.C.1
Jones, M.E.2
Schmitz, F.J.3
Acar, J.4
Gupta, R.5
Verhoef, J.6
-
3
-
-
0034777405
-
Four-year prospective evaluation of community-acquired bacteremia: Epidemiology, microbiology and patient outcome
-
DOI: 10.1016/S0732-8893-(01)00284-X
-
Lark RL, Saint S, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJ. Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology and patient outcome. Diagn Microbiol Infect Dis. 2001;41:15-22. DOI: 10.1016/S0732-8893-(01)00284-X
-
(2001)
Diagn Microbiol Infect Dis
, vol.41
, pp. 15-22
-
-
Lark, R.L.1
Saint, S.2
Chenoweth, C.3
Zemencuk, J.K.4
Lipsky, B.A.5
Plorde, J.J.6
-
4
-
-
13844254907
-
ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study
-
Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
-
(2005)
Lancet
, vol.365
, pp. 579-587
-
-
Goossens, H.1
Ferech, M.2
Vander Stichele, R.3
Elseviers, M.4
-
5
-
-
0038409785
-
Evolución del consumo de antibióticos en España, 1985-2000.
-
Lázaro BE, Madurga SM, de Abajo FJ. Evolución del consumo de antibióticos en España, 1985-2000. Med Clin (Barc). 2002;118:561-8.
-
(2002)
Med Clin (Barc)
, vol.118
, pp. 561-568
-
-
Lázaro, B.E.1
Madurga, S.M.2
de Abajo, F.J.3
-
6
-
-
34548138984
-
Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data
-
DOI: 10.1093/jac/dkm248
-
Campos J, Ferech M, Lázaro E, de Abajo F, Oteo J, Stephens P, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother. 2007;60:698-701. DOI: 10.1093/jac/dkm248
-
(2007)
J Antimicrob Chemother
, vol.60
, pp. 698-701
-
-
Campos, J.1
Ferech, M.2
Lázaro, E.3
de Abajo, F.4
Oteo, J.5
Stephens, P.6
-
7
-
-
48849116706
-
-
cited 2007 Jan 8, Available from
-
European Antimicrobial Resistance Surveillance System [cited 2007 Jan 8]. Available from http://www.rivm.nl/earss
-
-
-
-
8
-
-
48849115370
-
-
Clinical and Laboratory Standards Institute (CLSI, Wayne PA, The Institute;, cited 2008 Jun 27, Available from
-
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing - 17th informational supplement. M100-S17. Vol 27, No. 1. Wayne (PA): The Institute; 2007 [cited 2008 Jun 27]. Available from http://www.clsi.org
-
(2007)
Performance standards for antimicrobial susceptibility testing - 17th informational
, vol.27
, Issue.1 SUPPL.EMENT. M100-S17
-
-
-
9
-
-
0004100812
-
-
World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo Norway, The Organization;
-
World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo (Norway): The Organization; 2005.
-
(2005)
Guidelines for ATC classification and DDD assignment
-
-
-
10
-
-
0036174641
-
Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection
-
DOI: 10.1093/jac/49.2.367
-
Leflon-Guibout V, Ternat G, Heym B, Nicolas-Chanoine MH. Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection. J Antimicrob Chemother. 2002;49:367-71. DOI: 10.1093/jac/49.2.367
-
(2002)
J Antimicrob Chemother
, vol.49
, pp. 367-371
-
-
Leflon-Guibout, V.1
Ternat, G.2
Heym, B.3
Nicolas-Chanoine, M.H.4
-
11
-
-
0036896627
-
Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant period
-
DOI: 10.1128/AAC.46.12.3991-3994.2002
-
Miró E, Navarro F, Mirelis B, Sabaté M, Rivera A, Coll P, et al. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant period. Antimicrob Agents Chemother. 2002;46:3991-4. DOI: 10.1128/AAC.46.12.3991-3994.2002
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 3991-3994
-
-
Miró, E.1
Navarro, F.2
Mirelis, B.3
Sabaté, M.4
Rivera, A.5
Coll, P.6
|